Mastek is currently trading at Rs. 2535.05, up by 37.50 points or 1.50% from its previous closing of Rs. 2497.55 on the BSE.
The scrip opened at Rs. 2529.90 and has touched a high and low of Rs. 2570.15 and Rs. 2504.25 respectively. So far 3998 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3375.00 on 04-Dec-2024 and a 52 week low of Rs. 1882.90 on 07-Apr-2025.
Last one week high and low of the scrip stood at Rs. 2570.15 and Rs. 2341.05 respectively. The current market cap of the company is Rs. 7786.09 crore.
The promoters holding in the company stood at 35.97%, while Institutions and Non-Institutions held 19.86% and 44.18% respectively.
Mastek has been awarded a contract by NHS England to provide NHS board and Senior Information Risk Owner (SIRO) cybersecurity training in partnership with Templar Executives. This training is aimed at NHS Boards and executives to help enhance their understanding of the cyber landscape and build resilience across the healthcare system.
The one-year contract, with the option to extend for an additional year, will see Mastek and its partner Templar Executives, deliver tailored cybersecurity training specifically designed for NHS executive Boards and SIROs. The training will focus on equipping these critical leaders with the knowledge and skills needed to effectively manage cyber risks, ensure compliance with legislation, and foster a culture of cyber resilience within their organisations.
Mastek together with its subsidiaries, provides enterprise technology solutions and platforms for insurance, government, and financial services organizations worldwide.
| Company Name | CMP |
|---|---|
| TCS | 2394.85 |
| Infosys | 1179.20 |
| HCL Tech. | 1198.60 |
| Wipro | 197.95 |
| Tech Mahindra | 1463.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: